Perceptions of Benefit of Complementary Therapy Use among People with Diabetes and Cardiovascular Disease
Rachel Canaway, Lenore Manderson, Brian Oldenburg
FORSCHENDE KOMPLEMENTARMEDIZIN | KARGER | Published : 2014
BACKGROUND: Little is known about why and how people with type 2 diabetes and cardiovascular disease (CVD) use CAM, or of the perceived benefits of CAM use. The CAMELOT study explored care-seeking, self-management, costs, barriers and benefits of CAM use among this population. We report here on CAM used for treatment of diabetes and CVD, and non-clinical outcomes of CAM use. METHODS: Data were collected in 2009-2010 via in-depth interviews (n = 69) and a self-report questionnaire (n = 2,915) among people with diabetes and/or CVD, throughout an Australian state. Analysis included contingency tables, chi-square analysis and thematic coding of interview and long answer survey data. RESULTS: CAM..View full abstract
Awarded by Australian National Health and Medical Research Council
This research was funded by a grant from the Australian National Health and Medical Research Council (grant no 491171).